DTBRX
Price
$12.12
Change
+$0.09 (+0.75%)
Updated
Aug 1 closing price
Net Assets
49.37B
NEFRX
Price
$11.50
Change
+$0.09 (+0.79%)
Updated
Aug 1 closing price
Net Assets
7.58B
Interact to see
Advertisement

DTBRX vs NEFRX

Header iconDTBRX vs NEFRX Comparison
Open Charts DTBRX vs NEFRXBanner chart's image
PGIM Total Return Bond R
Price$12.12
Change+$0.09 (+0.75%)
VolumeN/A
Net Assets49.37B
Loomis Sayles Core Plus Bond A
Price$11.50
Change+$0.09 (+0.79%)
VolumeN/A
Net Assets7.58B
DTBRX vs NEFRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DTBRX vs. NEFRX commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTBRX is a Hold and NEFRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DTBRX has more cash in the bank: 49.4B vs. NEFRX (7.59B). DTBRX (4.12) and NEFRX (3.99) have matching dividends . DTBRX was incepted earlier than NEFRX: DTBRX (18 years) vs NEFRX (52 years). DTBRX (1.28) is less costly to investors than NEFRX (0.75). NEFRX is a more actively managed with annual turnover of: 170.00 vs. DTBRX (113.00). DTBRX has a lower initial minimum investment than NEFRX: DTBRX (0) vs NEFRX (2500). DTBRX annual gain was more profitable for investors over the last year : 3.10 vs. NEFRX (2.80). DTBRX return over 5 years is better than : -5.32 vs. NEFRX (-5.94).
DTBRXNEFRXDTBRX / NEFRX
Total Expense Ratio1.010.73138%
Annual Report Gross Expense Ratio1.280.75171%
Fund Existence18 years52 years-
Gain YTD3.6434.26186%
Front LoadN/A4%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets49.4B7.59B651%
Annual Yield % from dividends4.123.99103%
Returns for 1 year3.102.80111%
Returns for 3 years7.046.15114%
Returns for 5 years-5.32-5.9489%
Returns for 10 years14.3320.1571%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECTGX112.02N/A
N/A
Eaton Vance Tx-Mgd Growth 1.1 C
BPLEX10.37N/A
N/A
Boston Partners Long/Short Equity Inv
MAISX21.11N/A
N/A
Victory Integrity Small/Mid-Cap Value A
PTMCX18.58N/A
N/A
PGIM Quant Solutions Large-Cap Cor Eq C
OAZMX158.35-3.10
-1.92%
Oakmark R6